Merck's sac-TMT significantly cuts death risk in endometrial cancer
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Health & Medicine
Location of rare cancer impacts survival, study suggests
A rare, aggressive cancer, commonly found in the uterus, limbs and abdomen, behaves differently depending on where it is found in the body, according to new research.
Mumbai Sessions Court Rejects Astrologer’s Anticipatory Bail In ₹69.30 Lakh Cancer-Cure Fraud Case
Mumbai, October 26, 2026: A sessions court has refused to grant anticipatory bail to Rajshekhar Shashtri, a 39-year-old astrologer from Malabar Hill, who is accused of allegedly cheating a woman of Rs…
'No govt will use Ebola as political weapon' – NCDC boss
The Director General of the Nigeria Centre for Disease Control, NCDC, Dr Jide Idris, has said no government will use Ebola as a political weapon.
Nova Scotia woman targeted in swatting incident after suspected bank scam: RCMP
RCMP in Nova Scotia say a woman was the victim of a "swatting" incident after she refused to follow instructions from an alleged fraudster claiming to be from her bank.
Spatial Proteomics for Precision Oncology
In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples.
Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
Moderna CEO Stephane Bancel believes the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors.